What's Next For Esperion Therapeutics Inc (ESPR)?
Esperion Therapeutics Inc (NASDAQ:ESPR) picked up strength at the end of last week, on the back of some news that – at first glance – seems unrelated to its own operations.
Amgen Inc (AMGN)
Market is closed
News
- First
- << Previous
- 181 - 190
- Next >>
Gilead Sciences, Inc. (GILD) Is A Hail Mary: 3 Better Stocks To Consider
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences, Inc.
The Big Short’s Michael Burry Reveals His New Stock Picks
"Despite being one of the few prominent investors in the world to recognize the bubble brewing in the subprime mortgage markets and the crisis it would lead to when it burst, Michael Burry received only...
Is Amgen, Inc. (AMGN) A Good Stock To Buy Now?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips on the charts, usually don't make them change their opinion towards a company...
Highlights From Third Avenue's Investor Letters
Third Avenue Management is a New York-based investment fund that uses a deep value investing strategy for stock selection.
Why Wells Fargo, Gilead, Newfield, Amgen, and Chesapeake Energy Are Trending
All three indexes are in the green today after U.S. consumer confidence jumped to its highest figure in nine years during September.
Romosozumab From Amgen Inc (AMGN) Shows Positive Results In Osteoporosis
Romosozumab (AKA romo) from Amgen Inc (NASDAQ:AMGN) and Belgium-based UCB, which is in its Phase III FRAME study is yet to achieve any regulatory approval from the FDA until some time next year.
Coherus Biosciences Inc (CHRS) Has Set Its Sights On Amgen, Inc. (AMGN)
Coherus Biosciences Inc (NASDAQ:CHRS) submitted a biologics licensing application (BLA) for its lead biosimilar development candidate earlier this month, and is drawing a lot of speculative attention ...
Why ConocoPhillips, Amgen, Alere & Three Other Stocks Are Trending Today
Given that it's the middle of earnings season, it's not surprising that many major companies are trending today.
- First
- << Previous
- 181 - 190
- Next >>
Billionaire Hedge Funds
